ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
8 announcements
Sakar Healthcare Limited appointed M/s. Kashyap R. Mehta & Partners as the company's Secretarial Auditors for a five-year term, effective September 22, 2026, following shareholder approval at the AGM.
Sakar Healthcare's 22nd AGM was held on September 22, 2026, adopting audited financials and re-appointing a director. Routine resolutions were passed including secretarial auditor appointment.
Sakar Healthcare Q1 FY27 results show strong oncology pivot with 38% YoY revenue growth and 120% profit jump.
Sakar Healthcare reported strong Q1FY27 consolidated results with 38% Revenue growth and 120% PAT growth, driven by its vertically integrated oncology business and expansion into regulated markets.
Sakar Healthcare Ltd reported revenue from operations of ₹73 Cr (+38.5% YoY) and net profit of ₹10.3 Cr (+119.1% YoY) for Q1 FY27.
Sakar Healthcare Q4 FY26 revenue grew 42% YoY to ₹71.1cr with 37% EBITDA margins. Strategy focuses on transforming into a pure-play oncology exporter via its EU GMP facility.
Sakar Healthcare Q4FY26 presentation highlights a strategic shift toward high-margin oncology, leveraging a new EU-GMP integrated API-FDF facility in Bavla to drive specialized global healthcare solutions.
Sakar Healthcare Ltd reported revenue from operations of ₹71.1 Cr (+41.6% YoY) and net profit of ₹11 Cr (+89.7% YoY) for Q4 FY26.